mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.003 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.004 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.004 |